[DOI] [PubMed] [Google Scholar] 10.Richardson R.B., Ainsbury E.A., Prescott C.R., Lovicu F.J
When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage
March 2, 2026: Over 3,200 Claims Filed by Patients Who Took Rybelsus, Other GLP-1s As of March 2, 2026, there are 3,363 pending lawsuits in MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
For instance, in a study conducted before human trials, Sasakawa et al
Timing matters significantly: stop eating at least three hours before bed to allow gravity and stomach acid clearance to work naturally overnight
Electrolytes arent for everyone: Rethinking daily sodium intake February 21, 2026 By: Molly Piller Electrolyte supplements have become extremely popular on social media, driven by influencers and new brands that claim electrolytes are essential for hydration, skin health, energy, and even weight loss